MannKind Corporation (NASDAQ:MNKD) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. On June 19, ...

MannKind Corporation (NASDAQ:MNKD) is one of the 11 Best US Stocks to Invest in Under $5. MannKind Corporation (NASDAQ:MNKD) ...

MannKind to Present at Upcoming Investor Conferences. DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the ...

What:Shareholders of inhaled insulin maker MannKind Corporation are having a rough day. The company's stock is down more than 26% as of 12:30 p.m. EST Tuesday after MannKind reported its first ...

It took 10 years and $1 billion for MannKind Corp. in Valencia to get its breakthrough inhaled-insulin drug approved by U.S. regulators.

MannKind Corporation beats analysts on earnings and revenue in Q2 2023, with a year-over-year increase of 157.3% in revenue. Strong demand for Afrezza and Tyvaso DPI contributes to revenue growth.

Hours after MannKind Corp. announced on Tuesday that Sanofi had pulled out of an agreement to license its Afrezza inhaled insulin, a MannKind executive said the Valencia company does not plan to ...

What happened Shares of MannKind Corporation (NASDAQ: MNKD) were down 13.9% as of 3:31 p.m. EDT on Monday. The drop followed a 23% plunge on Friday.

Is the dreamboat envisioned by MannKind Corp. turning into something more akin to the Titanic? I've been a proponent of the biotech for quite a while, but it's hard to remain positive about ...

MannKind Corp., a California-based biopharmaceutical company, told nearly half of its employees at its Casper Street facility Thursday that they had been laid off, Matthew J. Pfeffer, the company ...

What happened Shares of MannKind Corporation (NASDAQ: MNKD) are soaring today, up 43% as of 9:35 a.m. EDT, following news that the company has struck.

MannKind taps investors for some much-needed capital. Shares of MannKind Corporation (NASDAQ: MNKD), the maker of inhaled insulin product Afrezza, are down by 15.3% in pre-market trading today on ...